May 23, 2024: With the BIOSECURE ACT being thwarted, American BioPharma companies are no longer worried about having their access to fast and cheap manufacturing out of China cut anytime soon.
BREAKING: Pfizer Announces $1.7 Billion in Severance Packages
With the BIOSECURE ACT being thwarted, Pfizer is decoupling from the US and European employment markets by moving their business investments and partnerships elsewhere, i.e. China.
